Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care

Launched by REGION SKANE · May 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a treatment approach called Brief Admission by self-referral (BA), which aims to help people who struggle with self-harm and related issues, such as borderline personality disorder. The goal of this study is to see if allowing patients to have more control over their care can reduce the need for compulsory hospitalizations. Researchers want to compare the outcomes of patients receiving this treatment to those receiving standard care, focusing on their experiences in the hospital and any potential impacts on their safety and well-being.

To be eligible for the trial, participants need to be between 18 and 65 years old and live in specific areas like Lund, Linköping, Helsingborg, or Norrköping. They should have a diagnosis of borderline personality disorder or have been hospitalized multiple times due to self-harm. Participants will receive the BA treatment and be monitored over time to assess the effects on their care. It’s important to note that this study is actively recruiting, so if you or someone you know fits the criteria and is interested in participating, it could be a valuable opportunity to explore a new way of receiving support.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Living in the uptake area of Lund, Linköping, Helsingborg or Norrköping
• • Age 18-65 years at the time of inclusion
• • Admitted to hospital either diagnosed with ICD-10 diagnosis BPD F60.3, or admitted at least twice with Intentional self-harm X60-83 in combination with one of more of the following diagnoses ADHD (F90.0-F90.X), Bipolar disorder type 2, (F31.8W, F318A-F, F31.0, F31.8-9, F31.8W) or Autism, Atypical autism, Aspergers syndrome (F84.0, F84.1, F84.5) or Mild intellectual disability (F70.0-F70.9).
• Exclusion Criteria:
• • not fulfilling inclusion criteria